JCOGでの多施設共同のGBMのゲノム解析の結果を、夏目敦至准教授と青木恒介助教が中心で公表しました。

JCOGでの多施設共同のGBMのゲノム解析の結果を、夏目敦至准教授と青木恒介助教が中心で公表しました。

Natsume A, Aoki K, Ohka F, Maeda S, Hirano M, Adilijiang A, Motomura K, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S, Okuno Y, Wakabayashi T; and Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG).
Genetic Analysis in Patients With Newly Diagnosed Glioblastomas Treated With Interferon-Beta Plus Temozolomide in Comparison With Temozolomide Alone. J Neurooncol. 2020 May 4. doi: 10.1007/s11060-020-03505-9. Online ahead of print.

https://link.springer.com/article/10.1007%2Fs11060-020-03505-9